Federal Circuit weighed in on patent eligibility of natural product claims. Non-eligibility in ChromaDex, Inc. v. Elysium Health, Inc. is not surprising, court chose to distinguish Natural Alternatives instead of characterizing decision as based on a unique procedural posture.